AMICUS THERAPEUTICS, INC. - Common Stock (FOLD)

Historical Holders from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
FOLD on Nasdaq
Shares outstanding
308,713,740
Price per share
$14.24
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
312,156,065
Total reported value
$2,459,923,997
% of total 13F portfolios
0.01%
Share change
-7,706,936
Value change
-$41,517,408
Number of holders
282
Price from insider filings
$14.24
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% $274,137,801 30,871,374 The Vanguard Group 28 Nov 2025
WELLINGTON MANAGEMENT GROUP LLP 9.5% $214,034,195 28,461,994 Wellington Management Group LLP 31 Dec 2024
BlackRock, Inc. 7.4% -21% $171,198,846 -$38,641,761 22,765,804 -18% BlackRock, Inc. 31 Mar 2025
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 5.2% +6% $125,877,122 +$9,421,352 15,974,254 +8.1% WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 30 Sep 2025
Avoro Capital Advisors LLC 4.9% -26% $118,397,000 -$43,143,000 15,025,000 -27% Avoro Capital Advisors LLC 30 Sep 2025
Redmile Group, LLC 4.6% $106,667,402 14,184,495 Redmile Group, LLC 31 Dec 2024
PERCEPTIVE ADVISORS LLC 2.4% -66% $43,290,927 -$82,061,910 7,412,830 -65% Perceptive Advisors LLC 30 Jun 2025
As of 30 Sep 2025, AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 282 institutional shareholders filing 13F forms. They hold 312,156,065 shares. .

Top 25 institutional shareholders own 76% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.6% 29,534,029 +0.43% 0% $232,728,149
WELLINGTON MANAGEMENT GROUP LLP 9.3% 28,628,829 -1.7% 0.04% $225,595,173
BlackRock, Inc. 8.4% 25,848,965 -6.1% 0% $203,689,844
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 5.1% 15,749,240 +7.6% 0.32% $124,104,011
Avoro Capital Advisors LLC 4.9% 15,025,000 -17% 1.5% $118,397,000
MILLENNIUM MANAGEMENT LLC 3.8% 11,809,796 +59% 0.07% $93,061,192
STATE STREET CORP 3.7% 11,562,939 -0.04% 0% $91,115,959
Vestal Point Capital, LP 3.2% 9,750,000 -18% 3.5% $76,830,000
CITADEL ADVISORS LLC 2.7% 8,250,140 +38% 0.05% $65,011,103
Point72 Asset Management, L.P. 2.3% 7,156,557 +118% 0.12% $56,393,679
BANK OF AMERICA CORP /DE/ 2.3% 7,109,070 +3.8% 0% $56,019,468
GEODE CAPITAL MANAGEMENT, LLC 2.3% 7,099,093 +5.9% 0% $55,950,545
Pictet Asset Management Holding SA 2.2% 6,788,164 +74% 0.05% $53,619,642
PERCEPTIVE ADVISORS LLC 2.1% 6,370,851 -14% 1.5% $50,202,306
Palo Alto Investors LP 1.7% 5,367,798 -4.3% 7.8% $42,298,248
Soleus Capital Management, L.P. 1.5% 4,690,000 2% $36,957,200
Nuveen, LLC 1.5% 4,622,397 +27% 0.01% $36,424,489
MACQUARIE GROUP LTD 1.5% 4,560,810 -41% 0.04% $35,939,000
D. E. Shaw & Co., Inc. 1.3% 3,868,210 -39% 0.02% $30,481,495
GOLDMAN SACHS GROUP INC 1.2% 3,784,218 -13% 0% $29,819,639
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.2% 3,708,738 -0.48% 0.01% $29,224,855
RICE HALL JAMES & ASSOCIATES, LLC 1.1% 3,434,717 +24% 1.5% $27,065,570
NORTHERN TRUST CORP 1.1% 3,337,375 +8% 0% $26,298,515
MORGAN STANLEY 1% 3,198,670 -25% 0% $25,205,520
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.89% 2,752,098 +8% 0% $21,686,532

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 152,305 $2,170,779 -$22,496,708 $14.24 6
2025 Q3 312,156,065 $2,459,923,997 -$41,517,408 $7.88 282
2025 Q2 319,344,550 $1,830,820,509 +$26,198,234 $5.73 269
2025 Q1 309,423,212 $2,526,512,925 +$26,438,324 $8.16 281
2024 Q4 305,140,281 $2,874,465,217 -$56,740,355 $9.42 286
2024 Q3 309,836,000 $3,309,105,094 -$75,379,629 $10.68 289
2024 Q2 315,168,068 $3,126,533,611 -$75,738,128 $9.92 256
2024 Q1 321,847,405 $3,791,483,281 +$26,707,749 $11.78 253
2023 Q4 318,908,725 $4,524,863,003 +$261,463,996 $14.19 226
2023 Q3 298,862,861 $3,633,462,965 -$93,168,939 $12.16 228
2023 Q2 307,102,100 $3,857,183,589 +$125,609,285 $12.56 212
2023 Q1 297,533,564 $3,299,196,032 +$66,985,676 $11.09 222
2022 Q4 292,444,452 $3,570,548,028 +$6,804,421 $12.21 225
2022 Q3 292,887,704 $3,053,948,950 -$136,712,515 $10.44 218
2022 Q2 305,130,656 $3,277,204,978 +$27,959,920 $10.74 197
2022 Q1 303,248,438 $2,872,272,289 +$16,415,995 $9.47 199
2021 Q4 301,421,729 $3,479,958,222 +$96,361,873 $11.55 215
2021 Q3 292,731,132 $2,798,448,068 +$153,922,424 $9.55 223
2021 Q2 276,914,599 $2,669,802,857 +$6,810,492 $9.64 222
2021 Q1 275,685,202 $2,723,386,669 -$230,544,914 $9.88 241
2020 Q4 279,155,505 $6,445,326,162 +$41,955,777 $23.09 267
2020 Q3 277,950,423 $3,923,978,054 -$60,291,396 $14.12 241
2020 Q2 281,585,235 $4,247,304,450 +$7,015,222 $15.08 217
2020 Q1 283,489,123 $2,618,877,274 +$72,473,358 $9.24 194
2019 Q4 275,145,261 $2,679,735,821 +$17,027,225 $9.74 211
2019 Q3 273,274,367 $2,191,232,241 +$7,544,973 $8.02 195
2019 Q2 268,775,703 $3,353,010,219 +$246,345,026 $12.48 202
2019 Q1 250,783,992 $3,410,473,734 +$284,627,731 $13.60 198
2018 Q4 231,135,366 $2,206,742,744 +$14,137,230 $9.58 182
2018 Q3 228,274,496 $2,760,074,376 -$4,704,604 $12.09 198
2018 Q2 226,320,420 $3,535,050,017 +$30,838,151 $15.62 196
2018 Q1 224,632,187 $3,376,722,825 +$286,532,653 $15.04 198
2017 Q4 205,784,956 $2,961,554,572 +$69,146,321 $14.39 181
2017 Q3 198,393,444 $2,990,825,396 +$373,880,068 $15.08 183
2017 Q2 174,164,391 $1,753,807,994 +$127,263,729 $10.07 138
2017 Q1 168,794,799 $1,203,523,835 +$168,107,989 $7.13 128
2016 Q4 156,858,667 $779,548,508 +$23,503,784 $4.97 130
2016 Q3 148,308,742 $1,096,923,417 +$112,419,698 $7.40 134
2016 Q2 136,917,771 $747,537,873 -$24,940,455 $5.46 124
2016 Q1 139,111,687 $1,175,012,113 +$7,378,238 $8.45 126
2015 Q4 138,735,633 $1,345,655,641 +$33,592,548 $9.70 136
2015 Q3 127,754,259 $1,760,477,682 +$206,267,066 $13.99 144
2015 Q2 112,532,503 $1,592,136,319 +$450,570,258 $14.15 137
2015 Q1 82,024,911 $890,563,041 +$47,434,297 $10.88 122
2014 Q4 79,806,156 $663,900,201 +$233,293,757 $8.32 109
2014 Q3 47,042,933 $279,906,000 +$43,116,058 $5.95 94
2014 Q2 40,677,308 $135,850,107 +$27,231,794 $3.34 60
2014 Q1 34,301,232 $71,016,802 -$323,725 $2.07 67